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Abstract
Background: While the prevalence of multidrug-resistant (MDR) tuberculosis (TB) is high among children in the Western
Cape of South Africa, the psychosocial implications of treatment for children with MDR-TB remain poorly understood. We
sought to explore how MDR-TB and its treatment impact children on an individual, familial, and social level.
Methods: Semi-structured interviews were conducted with 20 children and caregivers purposively sampled from a
prospective clinical cohort of children. The sample was stratified by age at the start of treatment (children >10 years, and
5-10 years). Caregiver proxy interviews were conducted with younger children, supplemented with child interviews;
older children were interviewed directly, supplemented with caregiver proxy interviews. Data were analysed using
grounded theory.
Results: Findings revealed pill volume and adverse effects produced significant physical, psychological and academic
disturbances in children. Adverse effects related to the medication were important obstacles to treatment adherence.
While there appear to be no long-lasting effects in younger children, a few older children showed evidence of
persisting internalised stigma. Caregivers suffered important treatment-related financial and psychological costs.
Community support, notably through the continued involvement of children in strong social networks, promoted
resilience among children and their families.
Conclusions: We found that the current treatment regimen for childhood MDR-TB has significant psychological,
academic, and financial impacts on children and their families. There is a need for psychosocial support of children
and caregivers to mitigate the negative effects of community stigma, and to manage the stressors associated with
chronic illness.
Keywords: South Africa, Childhood MDR-TB, Psychosocial impact, Qualitative research
Background
Drug-resistant tuberculosis (TB) was referred to as a pub-
lic health crisis in the 2013 World Health Organization
(WHO) Global TB Report. An estimated 450,000 people
developed multidrug-resistant (MDR)-TB (i.e. caused by
strains resistant to at least isoniazid and rifampicin) in
2012 [1], with childhood estimates as high as 32,000 in
2010 [2]. The treatment of childhood MDR-TB can be
challenging: typically, children are hospitalised when in-
jectable agents are administered (usually for the first 4 to
6 months), and continue outpatient treatment for a further
12 to 18 months [3-6]. Child-friendly drug formulations
remain scarce and medications are frequently unpalatable,
producing numerous adverse effects including nausea,
vomiting and diarrhoea [6,7]. However, the psychosocial
impact of MDR-TB and its treatment remain virtually un-
studied, and little is known about how children experience
long-term hospital admission, medication, and medicalisa-
tion resulting from the disease.
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A recent collection of children’s stories from the global
MDR-TB community described a number of psychosocial
challenges faced by these children worldwide, including
persisting stigma, abandonment, mental illness, and lack of
financial, emotional and parental support [8]. As a result,
we sought to obtain information concerning children’s in-
dividual, familial, and social experiences of MDR-TB, with
the aim of uncovering the impact of disease and treatment
on their lives. To our knowledge, ours is the first study to
use rigorous scientific tools to record, extract, analyse, and
examine the experiences of children following treatment
for MDR-TB. We anticipate that these study findings will
provide a framework for future interventions in the man-
agement of childhood MDR-TB.
Methods
Setting and study population
This study took place in the Western Cape province of
South Africa, one of the top MDR-TB high-burden set-
tings worldwide [1]. Provincial government estimates
from 2013 indicated between 450 and 600 incident cases
of MDR-TB (adult and children) are diagnosed in this
setting each year [9]. More generally, recent studies have
documented an increase in MDR-TB in South Africa, in-
cluding an increase in confirmed disease among children
[10,11]. Health outcomes for these children are variable:
a 2011 study indicated that 53% of 968 South African
children and adolescents with drug-resistant TB were
cured or completed treatment, while 24% died [12].
However, other reports show more than 90% cure or
treatment completion [13].
The Western Cape province is comprised of two do-
minant ethnic groups: Black African and Cape Coloured
(mixed race), who remain largely racially segregated across
neighbourhoods and townships [14]. The study sample
frame was comprised of a prospective cohort of 148 chil-
dren referred to the Tygerberg Children’s Hospital and
Khayelitsha outreach clinics who were started on treat-
ment for MDR-TB between 1st January, 2009 and 31st
December, 2010 [13]. Twenty children were purposively
sampled from this frame to obtain variation in ethnicity,
age and gender. Developmental considerations restricted
the sampling frame to children at least 5 years of age at
the start of MDR-TB treatment. Other exclusion criteria
included: children residing over one hour’s drive from the
research facility, families who were untraceable, or chil-
dren or caregivers who were not available for interviews.
Data collection
Primary caregivers were contacted by a TB counsellor to
obtain verbal consent allowing the child to take part in the
study. The study rationale and objectives were explained to
caregivers in their native language (isiXhosa/Afrikaans). To
minimise the methodological challenges of interviewing
children [15-17], participants were classified into two broad
age strata. Older children, at least 10 years of age at the
start of treatment, were interviewed directly, supplemented
thereafter with caregiver interviews. Younger children, be-
tween five and ten years of age at the start of treatment,
were interviewed by caregiver proxy, and subsequently dir-
ectly interviewed. Interviews took place in participants’
home or in the privacy of the researcher’s vehicle. All inter-
views were assisted by a research counsellor acting as an in-
terpreter for isiXhosa or Afrikaans-speaking participants,
the two dominant local languages. Questions followed a
semi-structured topic guide on the experience of diagnosis
and treatment, with specific discussion following partici-
pants’ narrative lead. Open data collection facilitated the
emergence of themes put forth in participants’ own narra-
tives, and the subsequent generation of theory grounded in
their accounts. The interpreter immediately translated par-
ticipant responses for the interviewer, who could speak nei-
ther language. All original isiXhosa and Afrikaans interview
recordings were later translated and transcribed by an in-
dependent translator so as to retain the highest degree of
response accuracy. English recordings were transcribed by
the first author. Data collection was terminated following
evidence of approaching data saturation.
Data analysis
Transcribed interview data were analysed by the first au-
thor, using principles of grounded theory [18]. Coded cat-
egorical themes were internally validated by comparative
analysis, whereby emerging themes were compared with
similar trends in the same and different interviews.
Memos were written to synthesise ideas and uncover the-
matic relationships across categories and between inter-
views. This process facilitated the recording of stages of
analytical development, serving as a platform upon which
to interpret the raw data and develop a comprehensive
theory. Interviews were subsequently re-read for evidence
of findings negating our theory. Finally, analyses were
cross-checked with co-authors and colleagues familiar
with the study context. This manuscript complies with the
RATS guidelines for reporting qualitative research [19].
Ethical considerations
Signed informed consent was obtained from the parent/
legal guardian (caregiver) for their interview, as well as on
behalf of the child. The child’s written assent was obtained
separately, where appropriate. Participants were assured of
confidentiality and anonymity in written work. All voice
files, transcripts, and consent/assent forms were safely
stored in the research facilities. This study was approved
by the Human Research Ethics Committee of Stellenbosch
University, Western Cape, South Africa, and the Ethics
Committee of the London School of Hygiene and Tropical
Medicine, London, UK.
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Results
A total of 36 children were identified who met the
eligibility criteria, from which 20 children were pur-
posively sampled (Additional file 1). The demographic
characteristics of the children interviewed are sum-
marised in Table 1. Of the caregivers contacted who
declined to participate, reasons included unavailability
during the study period, or time conflicts due to
employment.
Three broad themes were identified in participants’
narratives, including I) Problems with the clinical course
of treatment, II) Relationships with the self, and III) Re-
lationships with others. Themes and subthemes are pre-
sented and discussed within this framework.
Problems with the clinical course of treatment
Medications: adherence and adverse effects
The majority of respondents cited the large number of
pills and their adverse effects to be the most challenging
components of treatment.
The lot of pills. For a child, the pills are too big to
swallow. (Caregiver, 11a)
They make me feel dizzy. […] And they made me feel
pain in my stomach. (Child, 11b)
Oh, those drugs it is not for a child to use, […] because
a child’s system can’t hold them. (Caregiver, 11c)
Sometimes when I smell the pills, I just feel like I must
vomit. (Child, 11e)
Adverse effects coupled with exceptionally long treat-
ment duration rendered adherence difficult, particularly
among HIV-positive children concurrently taking anti-
retroviral therapy (ART) and treatment for MDR-TB.
You know, [my son] is having lots of pills now. HIV
pills and MDR, it’s too much. Even his MDR treatment
is more than mine. (Caregiver, 14a)
[During 4 months] I was hiding my pills. They were
not nice. (Child, 15b)
I thought to myself, ‘my medication is becoming more
and more, couldn’t it be less?’ Because the more it
Table 1 Demographic characteristics of study participants
Participant age & identifier* Sex Ethnicity HIV status Duration of hospital admission
Younger children (age 5-10 years at start of MDR-TB treatment)
7a F Black Negative 3 months, 6 days
7b F Black Positive NA
8 F Coloured Negative 5 months, 21 days
9a F Black Positive 7 months, 5 days
9b F Coloured Negative NA
10 F Black Positive 5 months, 9 days
11a F Coloured Negative NA
11b F Black Negative 5 months, 7 days
11c F Coloured Positive 13 months, 4 days
11d F Coloured Negative 4 months, 1 day
11e F Black Negative 4 months
12 F Coloured Negative 3 months, 18 days
Older children (age ≥10 years at start of MDR-TB treatment)
14a M Black Positive 3 months, 24 days
14b M Black Negative 6 months, 28 days
15a M Black Positive 19 months, 25 days
15b M Black Positive 4 months, 27 days
15c M Coloured Negative 2 months†
17a F Coloured Positive 8 months, 3 days
17b F Coloured Negative 1 month, 18 days
17c M Black Positive 1 month, 28 days
Abbreviations: F Female, HIV Human immunodeficiency virus, M Male, MDR Multidrug-resistant tuberculosis, NA Not admitted, received outpatient treatment.
*Unique identifiers were assigned to all participants. For example: “7a” refers to Child age 7, participant “a.” Ages are reported at the time of interview.
†Self-reported: admission/discharge dates unavailable.
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became, the lazier I became in taking them. I know
they are going to make me better, but I’m just tired of
[pills] because I have been taking [ART] from a young
age, as young as 3 years old until now. (Child, 17a)
I was not taking my pills. […] They were bitter and
they made me vomit. (Child, 17c)
The challenges of medical treatment were also felt by
caregivers, who reported frequent struggles to obtain
children’s cooperation:
“It was a fight when it came to the pills, every day.”
(Caregiver, 11a)
Academic impact
Children had access to in-hospital schooling during
their admission to Brooklyn Chest or Tygerberg hospitals.
When asked what they found most challenging following
their return to a normal academic institution, a few chil-
dren cited difficulties related to prolonged absenteeism.
They have classes [at Brooklyn Chest Hospital (BCH)],
but it’s not the same as normal school. I didn’t get
used to the longer days, because at BCH classes were
2 hours. At school it’s much longer, so that was hard.
The workload changed as well. But other than that it
was fine. (Child, 17b)
[What was most difficult was] when I started reading
again, because I couldn’t read Afrikaans [anymore].
(Child, 12)
Caregivers cited the challenges of children attending
school when experiencing adverse effects from the
medication.
Those tablets were making him very, very dizzy. I was
worried in the morning when he must go to school, you
can see he is dizzy. (Caregiver, 14a)
When the schools were closed she could eat her
treatment and then relax a bit, but there was no time
for that when she had to go to school. Those were the
times she would vomit.” (Caregiver, 11e)
Children who were made to repeat the same academic
grade found it easier to avoid questions in a new peer
group, whereas those who joined their old classmates in the
next grade faced more intense questioning and speculation.
When she went back to school, everyone was pointing
now. “There’s the girl that’s been out of school for
6 months.” (Caregiver, 11a)
The hardest part about going back to school was that my
friends were not going to ask me where I was and why I
was out of school for so long. If I had to tell them the truth
then their attitude towards me would change. (Child, 17a)
A few caregivers used the term “slow” to describe a
change in the child’s academic abilities, or even more
generally, their intellectual capabilities.
[A]fter that treatment she forgets everything. […] I’m
worried because when she did grade one before she
went to hospital, she was so clever, very, very brilliant.
(Caregiver, 9a)
She is a bit slow, she is not doing well at school anymore
so next year she is going to another school. I think [her
old friends] have noticed she is different, because she does
not play with the big children, she plays with the small
children. (Caregiver, 11c)
The school was calling me, she was very slow at her
work. (Caregiver, 11d)
While no cause was identified for this trend, decreased
academic performance and behavioural changes may be
attributed to a range of factors, including adverse effects
from medications, and the difficulty of returning to the
pace of a normal academic curriculum.
Financial impact
The financial impact of treatment on families was a dom-
inant theme. The most frequently cited expenditures in-
cluded travel to hospital and food-related expenses.
Sometimes it would be hard in terms of food, and then
I would not be able to give her the pills […] because
the pills would just sit in the stomach. (Caregiver, 7b)
It was very difficult for us when she got TB because we
can’t give her the food we eat, you see. […] Sometimes
the bread must have peanut butter, it must have jam,
must have a little bit of cheese—I can’t, I haven’t got
money. (Caregiver, 10)
We didn’t plan on this thing and now it’s out of our
budget. It’s taxi fare, and it’s staying in hospital…
(Caregiver, 11a)
Treatment-related expenditures were frequently com-
pounded with a loss of family income.
At the time I found out about [my child’s] condition I
was working, but then I lost my job while I was looking
after her in the hospital. (Caregiver, 7a)
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When she was [in hospital] it was so suffering. […] Because
I wasn’t working, my daughter was not working, then we
were travelling with the transport. (Caregiver, 11b)
The doctor also booked me off [of work] because [I also
had TB and] I might infect other people. (Caregiver, 14a)
Some respondents cited government grant payments
as helpful in offsetting the financial costs of treatment,
whereas others believed them to be insufficient.
When [the child was in hospital], the social worker
came to talk to me so I told her I went to cash loans to
borrow money, so I have to bring that money back
when I get my grant. […] Everything has gone back to
normal [now]. (Caregiver, 9a)
It’s only [my] husband that is working. […] One child
each gets R280, that is the “All Pay” [government
grant], and then it is the husband’s salary. Then it is
all the expenses that we have, you see. (Caregiver, 8)
[T]here came a time when we had to re-apply for [the
child’s] grant. Then [the] money was finished, so then
my mother helped me. (Caregiver, 14b)
While a minority of respondents claimed they had been
deemed ineligible for grant payments, it was not clear to
them why these had been denied.
Relationships with the self
Impact on self-perception
As evidenced from their ambitious future career aspira-
tions, most children experienced no negative treatment-
related impact on their sense of perceived self-efficacy.
[Fashion] modelling. (Child, 11b)
I will finish school, then I will go to college and after
college I want to work. (Child, 11d)
I want to play soccer. (Child, 14a)
I want to be a doctor. […] I saw that doctors help
people, they even helped me when I didn’t know if I
was going to live. (Child, 15a)
When asked whether TB had changed them, or their life,
in any way, most respondents reported no lasting change.
No, nothing [has changed]. (Child, 14a)
Not much has changed actually. I used to swim a lot. I
don’t swim as often but I still like swimming and it
doesn’t feel different. I run out of breath more easily
now, but other than that everything is fine.
(Child, 17b)
Respondents evidenced little self-blame for having
contracted MDR-TB.
How can [my son] not get TB because of the way he is
[child is cognitively impaired] and the place we are
living in? (Caregiver, 14b)
I just accepted it. […] I asked myself who I got it from
[…] but then I would answer myself by saying that
maybe I got it here because the place is dirty.
(Child, 15b)
I was sad because I’d started school, obviously when I
went back I would have lots of work to catch up on,
but other than that, nothing. […] I didn’t feel like it
was my fault. (Child, 17b)
A minority of respondents acknowledged a persisting
negative change in demeanour following TB treatment.
I would say that my attitude has changed because
when I had completed my treatment I was rude to
everyone. […] I’m alone most of the time, I only have
this one friend who also has TB, I just decided to
befriend her. (Child, 17a)
He changed now, when he came back from [the
hospital]. […] He is now a difficult child.
(Caregiver, 17c)
Overall, older children and adolescents appeared to
have internalised their condition to a greater extent than
did younger children.
Relationships with others
Disclosure of disease
Disclosure of MDR-TB status revealed four domin-
ant themes: selective, open, secondary, and no dis-
closure. Most respondents expressed selective disclosure
attitudes.
I told [some friends] that I have something in the air.
(Child, 11b)
I did tell some of [my friends] but not all of them.
(Child, 15a)
The people at home they know, and the lady who is
my next-door neighbour, she is the one person who
knew [my child] had TB. (Caregiver, 7a)
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Some respondents felt community disclosure to be
more problematic than disclosure in school.
It’s only [in our community], the complaint is only here
by us but at school I didn’t get complaints from her.
(Caregiver, 11d)
In my class they wrote a letter telling me to take my
pills when the doctor gives them to me. [But I did not
tell anyone else] because they are going to talk about
me here in the street, and that would hurt my feelings
if they talk about me. (Child, 14a)
A minority expressed liberal attitudes towards open
disclosure.
You know, my community [has disclosure issues]. But
I am very open-minded, and my family is very
open-minded, so as a result, it didn’t bother us much
[that everyone knew]. (Caregiver, 17b)
Yes I told [my friends]. […] [They] would ask me why
I’m taking my medication, I would then tell them that
I have TB, they then said ok. […] They were the same
[after TB], nothing changed. (Child, 17c)
One parent reasoned it was imperative to discuss
children’s illnesses among friends, “because we were a
group,” (Caregiver, 9b) suggesting a collective respon-
sibility to protect the community from disease. Anec-
dotes of inadvertent, secondary disclosure were not
uncommon, particularly as a consequence of clinic
visits.
The neighbours know. They asked because they could
see her going to the clinic all the time. (Caregiver, 7b)
You come to the day hospital, all the people are sitting
together, now everyone can see you are coming there to
wear a mask. It’s not private, all those people know
your business now. (Caregiver, 11a)
They see we go [to the clinic] and then they want
to know where we are going, and the people see
you walking over the fields… They know.
(Caregiver, 11d)
In the mornings I would be late for class if I had to go
to the clinic first. […] I also did not want to go in the
afternoons because then everyone would be at the
clinic. (Child, 17a)
Still other respondents avoided disclosure entirely,
choosing to keep such knowledge private.
It’s very hard for me to tell some of [my] friends,
because at the end of the day they will talk things to
him. (Caregiver, 14a)
I really do not feel comfortable discussing it with kids
my own age because you cannot predict what they
might do. They could tell other people then I would
look like the bad one, and as soon as people who do
not have TB start talking about TB, like in my class
for example, then I would feel uncomfortable and
guilty. (Child, 17a)
In the words of one concerned mother, “Here in these
flats, you can’t get sick.” (Caregiver, 11d) The caregiver
did not elaborate her statement further, suggesting only
that gossip was a serious problem in her community.
Stigma and fear of infection
Public stigma and a fear of being infected with MDR-TB
were frequently cited as drivers of respondents’ reluc-
tance to discuss TB status. However, only a few partici-
pants reported experiencing enacted stigma.
She always says that the kids tease her sometimes […]
[They call her] “half lung” and “you sick” and so on.
(Caregiver, 8)
[The neighbourhood children] call me names and they
hit me and stuff like that. [They would say] ‘TB thing,
just go away.’ They think I’m going to infect them.
(Child, 12)
Generally, social distancing was limited to the child
perceived to be infectious. Lack of education about TB
infectivity was cited as the underlying cause of stigma.
[Some] children don’t understand. And their parents
don’t understand. Because everybody knows about this
sickness. Sometimes, years before the treatment, the
people were scared somebody [would] come next to
them. (Caregiver, 10)
We live in a community that’s not very educated
about anything here. So it’s like, I keep my child here
and you keep your child there. (Caregiver, 11a)
One parent challenged this stigma by educating her
community about TB treatment.
I told [parents in the community] that it is not
dangerous because she is on treatment. Yes, I even told
them their cousins stayed with them so there is nothing
wrong, they live in the same house eating the same
food with the same dishes and spoons. (Caregiver, 9a)
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Another parent shared similar information with her
child’s peers.
I talked to [her friends] and I said, “You don’t get TB
when you are on treatment, if you are off treatment
[or] you don’t take your treatment, then you get TB.”
(Caregiver, 11d)
Promisingly, few respondents cited persisting stigma
once it was clear that children were no longer infectious.
Before she even finished treatment, everything was
back to normal. (Caregiver, 11a)
I talked to [my friends] and then when I coughed, they
would just say, ‘Keep your hand in front of your
mouth.’ They’re like normal [now]. (Child, 11d)
Among children who disclosed their TB status to their
peers, only one reported still experiencing stigma after
TB treatment.
Relationships within the family
The impact of treatment on family relationships was var-
ied, ranging from the dissolution of marriage to an in-
crease in family intimacy.
[My husband and I] argued because I stayed at the
hospital for a very long time and he felt like I cared more
about the child than I did for him. Then he left, and then
everything was my responsibility. (Caregiver, 15a)
You could really see that [my children] grew closer
together, in fact the whole family at the time.
(Caregiver, 17b)
Another caregiver refused to answer questions about
impact on family relationships.
I don’t want to talk about these things, really I don’t
want to talk. (Caregiver, 11d)
Family support was also evident, particularly with re-
spect to fulfilling the demands of childcare.
[The child’s mother] was very sick, she also had TB
and she slept a lot and did not have the strength to
get up and take care of the kids, so then my other
sister helped them out a lot. (Caregiver, 8)
The whole family was very supportive; they supported
me every time I must go to the hospital, they ask,
“Can I take you?” and the one can go to work or so.
(Caregiver, 9b)
My daughter would come [visit her sister in hospital]
every evening from work, my son was studying at the
time but he would also [visit her]. (Caregiver, 17b)
Overall, respondents whose stories evoked the involve-
ment of multiple family members during the child’s treat-
ment period appeared better able to share the burden of
illness relative to caregivers without such support.
Health costs to family members
Although self-reported adverse psychological effects among
caregivers were relatively infrequent, these were particularly
acute among those who had sustained previous trauma.
When [my daughter] became ill, it seemed like I was
also going down […]. It felt like my body just couldn’t
take it anymore, because my [other] baby passed on
because she had diarrhoea […]. Everything was too
much for me. (Caregiver, 11c)
I was very sad because I lost a daughter to leukaemia,
and now my husband got extremely drug-resistant TB
[XDR-TB], and my baby got TB, and a lot of things go
wrong. (Caregiver, 11d)
An elderly caregiver reported similar psychological
stress and ensuing adverse health effects.
I was very upset, I didn’t feel right, I got sick myself.
[…] I’m diabetic and have high blood pressure. I was
worse by the time she was sick. (Caregiver, 9a)
For some, caring for a chronically ill child was accom-
panied by feelings of guilt.
There were times that the [four] kids [at home] had to
sleep alone, and the father was working and I had to
ask other people to look after them, so I couldn’t be
there for them. I was torn up. (Caregiver, 11a)
In spite of their own struggles however, caregivers fre-
quently prioritised the child’s wellbeing above all else.
I said [to my son], “Yes, I will visit you [in hospital]
because I love you, ever since I am a mother for you. I
make everything for you, don’t worry.” (Caregiver, 14a)
I did everything possible for [my daughter]. […] They
would give me the medication and I would administer.
I would bathe her, all of that. (Caregiver, 17b)
Mitigating effect of social support
Children admitted to hospital were allowed to return home
every second weekend, so as to minimise interference with
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the injection schedule, and appeared to draw great com-
fort from their continued inclusion in familiar social
networks.
After a month, [the hospital] gave [my child] to me on
weekends, and they also taught me the right way of
giving her pills. (Caregiver, 9a)
Every second weekend [my friends came to see me]
when I came home from hospital. (Child, 12)
[Her friends at school] missed her, the children made
cards for her. (Caregiver, 12)
On my 16th birthday my aunt and her church people
came and they also brought along some sweets for me.
[…] I was so happy to see them because I never
thought that they would visit me. (Child, 17a)
Furthermore, internalised stigma was reduced when
children learned of individuals whose social status chal-
lenged the negative associations of people who develop
TB disease.
I said to [my brother] “you are not shy [about taking
TB treatment]!” The girls go crazy over him. He would
then ask why he should be shy, because there are a lot
of gangsters who are sick who go to the clinic as well.
So then when he takes his tablets I would take my
tablets as well. (Child, 17a)
Teachers took on supportive roles for both children
and caregivers, including helping to monitor the child at
school and administer treatment.
I had to involve the teacher in school as well, and then
she would drink [her pills] with the teacher […]. So me
and the teacher had to communicate with each other
on a regular basis. (Caregiver, 11a)
Oh the school, they really did support us, all the way.
(Caregiver, 11d)
[T]he teacher phoned her twice a week just to find out
how she’s doing. (Caregiver, 12)
[The children in school] started making fun of [my
child] and the teacher told her, “Just ignore them.”
Afterwards she had a chat with [the children] and
told them what MDR-TB is all about. (Caregiver, 12)
My teacher phoned [the hospital] from his classroom. I
cried on that day because I missed my classmates and
I missed everyone at home. (Child, 17a)
Teachers’ attentiveness to children and caregivers’ needs
was conducive to both emotional and social rehabilitation,
as well as to facilitating the management of at-home care.
Discussion
This exploratory study revealed that children’s experiences
of MDR-TB treatment were heterogeneous. Importantly,
the key findings emerging from the present study echo the
stories of children affected by MDR-TB worldwide. A re-
cently published collection of 30 stories of children affected
by MDR-TB from 30 different countries revealed the crit-
ical need for a comprehensive approach to MDR-TB treat-
ment [8]. In addition to the urgent need for improved
diagnostics and child-friendly TB drug development, these
stories demonstrate that psychosocial support interven-
tions including pain management, hearing tests, nutritional
support, and travel allowances are equally instrumental to
positive health outcomes for children and their families.
Findings from the current study confirmed what is
known about TB treatment: pills are unpalatable and ex-
cessive in number, and adverse effects are highly disrup-
tive, producing little incentive for children to remain
adherent to treatment [7,20]. Furthermore, medications
frequently produce acute academic disruptions, sometimes
persisting beyond the termination of treatment. In particu-
lar, some children may be at higher risk of experiencing
cognitive treatment-related adverse effects, including vari-
ous psychiatric disorders [21,22]. These may in turn have
consequences for the child’s long-term academic and so-
cial reintegration. Brief psychosocial screenings would
help identify those children at risk prior to the start of
MDR-TB treatment.
Similarly, assessments of caregivers could also identify
individuals at risk of experiencing pathological stress, anx-
iety, or depression. While most respondents did not report
changes in family relationships, a minority highlighted
acute distress, including spousal separation. Research has
shown that caregivers may experience high levels of
disability-related stress resulting from the strain of dealing
with a chronically ill child [23]. This was evident in care-
givers’ accounts of their own physical and mental health
struggles, which were frequently aggravated during the
child’s illness. In turn, children’s psychological vulnerabil-
ity is especially pronounced when parents suffer from
poor health or emotional distress [24]. As caregivers al-
most always accompany children to medical appoint-
ments, health professionals could use this setting to assess
the presence of stressors which may impact on caregivers’
well-being and management of childhood illness [25].
Virtually all caregivers reported financial difficulties
resulting from treatment-related expenditures. Despite
financial distress however, most caregivers paid regular
visits to children in hospital. Currently, all TB treatment
(including treatment for MDR-TB) and hospitalisation is
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free of charge for all public sector patients in South
Africa. In addition, government grants offer child sup-
port payments (Totalling R280 [USD 26] per month in
2012) to couples earning a combined salary of less than
R5,600 (USD 524) per month, or to single parents with a
salary of less than R2,800 (USD 263) per month [26].
This grant is available to parents for each child under
18 years of age. If a child is unwell, however, family ex-
penditures can exceed support payments, particularly if
caregivers are unemployed. Caregivers who qualify for
grants are informed by social workers at both Tygerberg
and Brooklyn Chest hospitals; however, it is unclear
what proportion of respondents in this study had access
to grant payments, or whether any remained unaware of
their existence.
In agreement with our findings, a recent systematic re-
view on the pathways of TB stigma revealed the most
common cause of stigma to be the perceived risk of trans-
mission to vulnerable individuals [27]. While knowledge
interventions are especially effective against such ins-
trumental stigma [28], interventions must simultaneously
guard against inadvertently contributing to an increased
fear of infection due to the prevalence of self-protection
messages [29]. Given its protective function, education in-
terventions could reduce instrumental stigma, but are
unlikely to eliminate it altogether. Interventions should
therefore aim to target stigma that is unjustified in terms
of self-protection, including the avoidance of a child who
is no longer clinically infectious.
With the exception of a few adolescents who displayed
signs of internalised TB stigma, most children did not
appear to suffer lasting adverse effects. Importantly, chil-
dren who did not internalise stigma also tended to ex-
perience strong community, family, and peer support.
Some evidence suggests that involving role models in
TB discourse could further guard against self-stigma, for
instance, by elevating respected public figures who sur-
vived TB disease. Research originating from the Eastern
Cape revealed that few citizens were aware such figures
included Nelson Mandela and Desmond Tutu [30]. In
addition, a recent study found that schoolchildren in
high-burden TB settings were key players in the broader
communication of TB information [31]. Schools should
therefore encourage classroom discussions of TB stigma,
its consequences, and provide resources to which chil-
dren could turn for psychosocial support.
This study has several potential limitations. Time con-
straints restricted the sampling strategy to participant
availability. The use of an interpreter may have resulted in
information omissions and misinterpretations. Additional
limitations included the use of caregiver proxy interviews
to substantiate children’s experiences. All participants may
have been subject to interviewer and recall bias, with the
potential for additional bias resulting from the demand
characteristics of the research setting: children’s desire to
please may sometimes outweigh their desire to be truthful.
Lastly, the interviewer’s association with a research organ-
isation could have reduced participants’ willingness to ex-
press criticism towards health care workers or medical
treatment.
Conclusions
The current treatment regimen for MDR-TB is problem-
atic in terms of its duration, complexity, and the adverse
events associated with medications. Although there appear
to be no long-lasting effects in younger children, they, like
all children, would strongly benefit from a shorter, more
manageable treatment regimen. Finally, there is a need for
psychosocial support of both children and caregivers to
mitigate the potential negative effects of stigma, and help
them manage difficulties related to disclosure. Multi-level
interventions should aim to provide a framework of sup-
port for children and their families, beginning at the time
of diagnosis and continuing into the child’s outpatient
treatment.
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